Analysis of HCV resistance mutations during combination therapy with protease inhibitor boceprevir and PEG-IFN alpha-2b using TaqMan mismatch amplification mutation assay (Q42981143)
Jump to navigation
Jump to search
scientific article published on 11 September 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Analysis of HCV resistance mutations during combination therapy with protease inhibitor boceprevir and PEG-IFN alpha-2b using TaqMan mismatch amplification mutation assay |
scientific article published on 11 September 2008 |
Statements
1 reference
Analysis of HCV resistance mutations during combination therapy with protease inhibitor boceprevir and PEG-IFN alpha-2b using TaqMan mismatch amplification mutation assay (English)
1 reference
Stephanie Curry
1 reference
Ping Qiu
1 reference
Xiao Tong
1 reference
11 September 2008
1 reference
1 reference
153
1 reference
2
1 reference
156-162
1 reference
Identifiers
1 reference
1 reference